x
Peter Anastasiou
CEO
Capsida Biotherapeutics, Inc
Peter Anastasiou
CEO

x
Christopher Boerner, PhD
Chief Commercialization Officer
Bristol Myers Squibb
Committee member
Christopher Boerner, PhD
Chief Commercialization Officer

x
Randall Bradford
Executive Vice President, Group Human Resources, Head of Human Resources, Healthcare
Merck KGaA, Darmstadt Germany
Committee member
Randall Bradford
Executive Vice President, Group Human Resources, Head of Human Resources, Healthcare

x
Judy Brown
SVP Corporate Affairs
Amgen Inc.
Judy Brown
SVP Corporate Affairs

x
Charles DeWildt*
Chief Commercial Officer
Neurelis, Inc.
Committee member
Charles DeWildt*
Chief Commercial Officer


*Non-voting member
x
Jag Dosanjh
President, U.S. Neuroscience and Eye Care
AbbVie Inc.
Committee member
Jag Dosanjh
President, U.S. Neuroscience and Eye Care

Jag Dosanjh is President, U.S. Neuroscience and Eye Care at AbbVie. In this role, he is responsible for leading the commercial business representing a strong portfolio of major brands across many different disease areas. Jag joined Allergan in 2011 and served in a variety of roles with increasing responsibility, including in Aesthetics, managed markets and global strategic marketing, and most recently served as Senior Vice President, Medical Therapeutics, overseeing BOTOX Therapeutic and Eye Care. Prior to this, Jag worked at GlaxoSmithKline for over 15 years in several executive positions in both Europe and United States with key areas of focus being Vaccine biologicals and Respiratory medicine. Jag holds a BA (Hons) degree in Business Studies from Sheffield Hallam University in the UK.
x
Eric Dube
President and CEO
Travere Therapeutics
Eric Dube
President and CEO

x
James Gillespie
president
Center for Healthcare Innovation
Committee member
James Gillespie
president

x
Otis Johnson
Chief Diversity, Inclusion & Sustainability Officer
Clario
Committee member
Otis Johnson
Chief Diversity, Inclusion & Sustainability Officer

Otis Johnson, PhD, Chief Diversity, Inclusion and Sustainability Officer, Clario A founding member of the Clinical Trial Optimization team at Merck and former head of Feasibility and Clinical Informatics at both ICON and Syneos Health, Otis Johnson is an accomplished clinical research professional and award-winning diversity, equity and inclusion (DEI) leader. In his 22 years working in the pharmaceutical industry, he has held leadership positions at a number of global healthcare companies, including Merck and Clario. At Clario, he served in the C-Suite as Product Line Executive for one of 6 major products and is now the Chief Diversity, Inclusion and Sustainability Officer. He works with employees, customers and shareholders to ensure they fulfil their environmental, social and governance (ESG) responsibilities. Otis was recently named to the prestigious Pharmavoice100 list of most inspiring industry leaders, shortlisted for the 2022 Informa Connect Impact Leader award for his Environmental Sustainability work and named a Mogul Top 100 DEI leader for 2 consecutive years. He serves on the diversity advisory boards of the Association of Clinical Research Organizations (ACRO) and the Association of Clinical Research Professionals (ACRP). He is also on the advisory board of the Wake Forest University’s Master’s Degree Program in Clinical Research Management and will serve on the board of the Healthcare Businesswomen Association (HBA) starting January, 2023.
x
Michelle Keefe
CEO
Syneos Health
Committee member
Michelle Keefe
CEO

Michelle is a global life sciences executive with 30+ years of commercial and clinical Go to Market, operational and financial expertise, and a proven track record of creating cross-collaborative, agile teams that accelerate product development success. She leads with a strong strategic focus to deliver growth and long-term value for shareholders, customers, employees and communities, in existing, start–up and acquisition environments. She joined Syneos Health® in 2017 and serves as President, Commercial Solutions, with leadership oversight of an insights-driven multi-disciplinary commercial organization including Deployment Solutions, Communications, and Consulting. This team delivers innovative, integrated solutions including accelerated patient clinical trial recruitment and optimized brand launch. Syneos Health brings together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Previous to Syneos Health, Michelle held leadership positions at Publicis, The Visiting Nurse Service of New York and Pfizer.  A champion for inclusive, collaborative cultures, Michelle is an Executive sponsor of the Syneos Health Women’s Group, Diversity, Equity & Inclusion Council and Syneos Heath Rising Star and Luminary employee recognition program. Throughout her career she’s held a steadfast commitment to developing and guiding others, serving on HBA’s Metro Chapter’s advisory board 2013-2017 and mentoring in the HBA mentorship program 2015-2017. Michelle received her B.S. Marketing from Seton Hall University, NJ, and completed coursework at Wharton Aresty Institute of Executive Education and PDI Ninth House General Management Assessment Center 2012 (now Korn Ferry).
x
Simona King
Chief Financial Officer
Passage Bio
Simona King
Chief Financial Officer

Simona is a strategic leader with over 20 years of diverse finance and business experience in the pharmaceutical industry. Simona is currently EVP and Chief Financial Officer at Tmunity, a cell and gene therapy biotech. Prior to that she was at Emergent BioSolutions, as vice president, finance and assistant treasurer, overseeing the financial planning and analysis and treasury organizations, and helped raise $450M in capital financing. Before joining Emergent BioSolutions, Simona spent 19 years at Bristol-Myers Squibb (BMS) most recently as executive director, head of global corporate financial planning and analysis. She started her career with BMS in 2000, and has consistently demonstrated strong leadership in a variety of finance roles of increasing responsibility within global manufacturing, mergers and acquisitions, research & development, enterprise services and US pharmaceuticals, as finance lead for the cardiovascular, neuroscience, diabetes and Puerto Rico businesses. Simona also worked at the board of governors of the Federal Reserve in Washington, DC and in banking in South Africa. Simona serves as vice-chair on the global board of directors of the Healthcare Businesswomen’s Association (HBA). She has a BA in economics from Kalamazoo College, an MBA in finance from Columbia University, a Diploma in African Studies from the University of Cape Town and is a certified public accountant. Originally from Romania, Simona resides in Bethesda, MD with her husband, three active children and family dog. She enjoys travel, beach, exercise and family time.
x
Rae Livingston
Chief Equity Officer
AbbVie Inc.
Rae Livingston
Chief Equity Officer

Rae Livingston serves as AbbVie’s Chief Equity Officer. In this role, she leads company-wide efforts to address the issues of race, equality and diversity – both inside and outside of AbbVie. She previously served as Vice President, Business Human Resources, Corporate Functions and U.S. Employee Relations since she joined AbbVie in 2016. Prior to joining AbbVie, Ms. Livingston held several positions of increasing global responsibility with Rockwell Automation, where she most recently served as the vice president of human resources for headquarters functions, culture of inclusion and mergers and acquisitions. She also gained key experience in business human resources and mergers & acquisitions with Medtronic, Inc. and JP Morgan Chase, both in the United States and abroad. Ms. Livingston has served as board chair for the YWCA of Southeast Wisconsin and as a member of the executive committee. In 2021, she was recognized by Diversity Woman Media’s Elite 100 list, as one of a hundred extraordinary Black women executives changing the face of corporate America. She earned her bachelor’s and master’s degrees in business administration from Florida Agricultural and Mechanical University and is a certified senior professional in human resources (SPHR).
x
Hayden Majajas
Head of Global Diversity, Equity & Inclusion
Takeda Pharmaceuticals, Inc.
Committee member
Hayden Majajas
Head of Global Diversity, Equity & Inclusion

x
Christine Miller
President & Chief Executive Officer
Melinta Therapeutics
Christine Miller
President & Chief Executive Officer

x
Kabir Nath
Chief Executive Officer
Compass Pathways
Committee member
Kabir Nath
Chief Executive Officer

Kabir Nath has approximately thirty years of experience in the biopharmaceutical and medical device industry. Prior to joining COMPASS, Kabir was Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co., Ltd. and, before that, President and CEO of Otsuka’s North America Pharmaceutical Business, where he led the development of pharmaceutical products and digital solutions addressing complex mental health needs. Kabir has also held various leadership positions at Bristol Myers Squibb, a global biopharmaceutical company focused on innovative medicines for patients with serious diseases. Kabir holds an MA from the University of Cambridge and an MBA from INSEAD.
x
Kinnari Patel
President & COO
Rocket Pharma
Committee member
Kinnari Patel
President & COO

x
Liz Paulson
Senior Director of Life Sciences Sales
LexisNexis Health Care - Elsevier
Committee member
Liz Paulson
Senior Director of Life Sciences Sales

Liz Paulson has over 25 years of varied experience in healthcare as a provider, a sales and marketing executive, and in the clinical research sector. Currently Ms. Paulson serves as a Account Executive at LexisNexis Healthcare. She works with claims data to develop commercial strategies for pharmaceutical, biotechnology and medical device companies and is the chair of the Women’s Connected group for King of Prussia. Prior to joining LexisNexis, Liz worked in the development of new product offerings, marketing and sales at Adheris an inVentiv Health company. Liz has also worked in Health Economics and Outcomes Research at i3 Innouvs (now Optum), Pharmetrics, and IMS. Prior to her work in Health Economics, she worked in sales for Eli Lilly. Prior to working in the Pharmaceutical and Biotech sector, she worked within the Departments of Mental Health and Developmental Disabilities in Massachusetts, providing behavioral consulting and emergency services to patients. In addition, she worked to develop medication training programs across both DMH and DDS, to foster patient compliance, and reduce hospitalizations. Ms. Paulson holds a B.A. in Psychology from the Catholic University of America in Washington, D.C. She has been a member of the Healthcare Businesswomen’s Association Boston Chapter since 2004, volunteering on the membership and programs committee, and has held all positions on the Executive Committee for the Boston Chapter and is currently serving her second year on the HBA corporate board as the lead for the regional councils and all chapter and affiliate executive teams. In her free time she coaches girls soccer and basketball.
x
Pamela Puryear
EVP, Global Chief Human Resources Officer
Walgreens Boots Alliance
Pamela Puryear
EVP, Global Chief Human Resources Officer

x
Christi Shaw
CEO
Gilead Sciences
Christi Shaw
CEO

x
Erik Smith
principal, strategy & analytics, life sciences
Deloitte LLP
Committee member
Erik Smith
principal, strategy & analytics, life sciences

Erik D. Smith, Ph.D. is a Principal with Deloitte Consulting’s Strategy Practice. For over 15 years, he’s worked across health care, including manufacturers, payers, providers and others in the space – both in the US and around the world. The majority of Erik’s work has focused on the commercial side of bio-pharma, covering corporate, BU, franchise, product and country levels, across numerous therapeutic areas, asset and product stages. Erik has delivered new strategies and tested those already in use, for clients at all levels, including Boards. He’s launched innovation initiatives, and updated risk management programs. Erik brings particular expertise in understanding uncertainty, both for long-term strategy and for short-term tactics. He’s an advanced user of scenario planning and other simulation approaches, has published on the subject, and taught training courses. With HBA, Erik has served on the Advisory Board of the San Francisco Bay Area Chapter, and more recently on the Advisory Board for the West Region as well as the Strategic Alliances Committee for the Board. Erik holds both a Ph.D. in demography and an M.A. in socio-cultural anthropology from University of California. Berkeley, and a B.A. in political science, with minors in social ecology and philosophy, from UC Irvine.
x
Susan Torroella
Chief Executive Officer
Susan Torroella
Chief Executive Officer

x
Ruth Williams-Brinkley
president, Kaiser Permanente Health Plan and Hospitals of the Northwest
Kaiser Permanente
Ruth Williams-Brinkley
president, Kaiser Permanente Health Plan and Hospitals of the Northwest